Report #2857489

Received Sep 9, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 79 yrs
State: NY
Recovered: Recovered
Vaccinated: May 29, 2025
Onset: May 29, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	1	UNK	IM / LA

Symptoms (1)

Somnolence

Symptom narrative

Sleepiness; This non-serious case was reported by a consumer via call center representative and described the occurrence of sleepiness in a 79-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. On 29-MAY-2025, the patient received the 1st dose of Shingrix (intramuscular, left arm). On 29-MAY-2025, less than a day after receiving Shingrix, the patient experienced sleepiness (Verbatim: Sleepiness). On 30-MAY-2025, the outcome of the sleepiness was resolved (duration 24 hrs). It was unknown if the reporter considered the sleepiness to be related to Shingrix. It was unknown if the company considered the sleepiness to be related to Shingrix. Additional Information: GSK receipt date: 20-AUG-2025 Reporter and his wife both received their first dose and are scheduled for the second dose as PI recommends. Reporter stated that his wife was very sleepy the entire day.; Sender's Comments: US-GSK-US2025107983:same reporter